NIH-funded research R01 grant

Physiologic marker to predict cerebral palsy early in high-risk babies

Official title: Physiomarker for early, equitable cerebral palsy prediction

Funded at University of Virginia · NIH-11397264 · Data updated 2026-11-12

Aims to create an early, easy screen using NICU vital signs to flag infants at higher risk for cerebral palsy so families can get timely follow-up.

More Cerebral Palsy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startAugust 11, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$615,486
NIH project number5R01HD119199-02
Project IDNIH-11397264 on NIH RePORTER

Who could benefit from this research

Could help

Premature infants and other NICU patients who are at high risk for cerebral palsy and are receiving continuous vital-sign monitoring.

Less likely to help

Infants without CP risk markers or those not in NICU care may not benefit from this screening approach.

What this research studies

This project will analyze continuous NICU heart-rate and other vital-sign data from premature infants to identify early physiologic patterns that signal risk for cerebral palsy. Using advanced time-series analysis and the FAIRSCAPE platform for sharing data, researchers hope to develop a practical biomarker that can be applied across NICUs. If successful, the tool would help clinicians refer babies sooner for CP-specific evaluations and therapies, improving developmental outcomes. The work involves collaboration across data science and pediatric neurology teams and will rely on high- and low-resolution waveform data.

Why it matters

Potential benefit: If successful, the physiomarker could enable earlier detection and intervention for cerebral palsy, potentially improving development and quality of life for affected children.

How similar studies have gone: Preliminary observations suggest distinct NICU heart-rate patterns in infants who later develop CP, indicating potential for a predictive biomarker.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Letzkus, Lisa — University of Virginia
  • Study coordinator: Letzkus, Lisa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.